| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/04/1993 | WO1993001817A1 Antiviral compositions comprising fusidic acid, l-ascorbic acid and salicylic acid and derivatives |
| 02/04/1993 | WO1993001816A1 Method and composition for treatment of gastric and duodenal disorders and new pge2-derivatives |
| 02/04/1993 | WO1993001815A1 Drug for preventing and/or treating allergic disease |
| 02/04/1993 | WO1993001814A1 Oxicam or oxicam derivatives-containing ophthalmic compositions |
| 02/04/1993 | WO1993001813A1 Platelet activating factor antagonists |
| 02/04/1993 | WO1993001812A1 S-(3-(4(5))-imidazolyl)propyl)isothiourea as selective trhistomine h3 receptor antagonist |
| 02/04/1993 | WO1993001811A1 Method of preparing a sterile-filterable solution of an active substance |
| 02/04/1993 | WO1993001809A1 Pharmaceutical formulations comprised of micronised halofantrine |
| 02/04/1993 | WO1993001776A1 Device for administering bimakalim transdermally |
| 02/04/1993 | WO1993001717A1 Modulation and diagnosis of cytokine dysfunctions |
| 02/04/1993 | WO1993001714A1 Mixtures with an antimicrobial action |
| 02/04/1993 | WO1992018475A3 Substituted phenylazacycloalkanes as cns agents |
| 02/04/1993 | WO1992013950A3 NUCLEOTIDIC SEQUENCES CODING FOR VARIABLE REGIONS OF β CHAINS OF HUMAN T LYMPHOCYTE RECEPTORS, CORRESPONDING PEPTIDIC SEGMENTS AND DIAGNOSTIC AND THERAPEUTIC APPLICATIONS |
| 02/04/1993 | DE4125255A1 Prostaglandin e (pfeil abwaerts)1(pfeil abwaerts)-formulierung Prostaglandin E (Down Arrow) 1 (down arrow) formulation, |
| 02/04/1993 | CA2114111A1 Microbial mixtures |
| 02/04/1993 | CA2114023A1 Method and composition for treatment of gastric and duodenal disorders and new pge2-derivatives |
| 02/04/1993 | CA2114009A1 Novel benzopyrido piperidylidene compounds, compositions, methods of manufacture and methods of use |
| 02/04/1993 | CA2113817A1 A method for treatment of metabolic disorders |
| 02/04/1993 | CA2113644A1 Retroviral protease inhibitors |
| 02/04/1993 | CA2113614A1 Antimicrobial treatment methods and compositions |
| 02/04/1993 | CA2113573A1 Modulation and diagnosis of cytokine dysfunctions |
| 02/04/1993 | CA2113568A1 2-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
| 02/04/1993 | CA2113475A1 Novel 6-substituted steroids, methods for producing same and pharmaceutical compositions containing said steroids |
| 02/04/1993 | CA2113449A1 Piperazine derivatives and pharmaceuticals containing the same |
| 02/04/1993 | CA2113185A1 The preparation of an active substance solution which can be sterilized by filtration |
| 02/04/1993 | CA2112689A1 Indoles |
| 02/04/1993 | CA2112678A1 Indoles |
| 02/04/1993 | CA2112562A1 Platelet activating factor antagonists |
| 02/04/1993 | CA2112561A1 Benzodiazepine derivatives, compositions containing them and their use in therapy |
| 02/04/1993 | CA2111972A1 Prevention and reduction of severity of traumatic injury |
| 02/03/1993 | WO1993003013A1 Indoline derivatives having an amide function, their preparation, and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526434A1 Benzimidazolone derivatives as 5-HT1A and 5-HT2 antagonists |
| 02/03/1993 | EP0526402A1 Heteroaryl substituted hydroxylamine derivatives as lipoxygenase inhibitors |
| 02/03/1993 | EP0526395A1 Arylalkylamine derivatives, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526348A1 Indoline derivatives carrying an amide function, their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526342A1 Isoquinolin-5yl-sulphonamides, process for their preparation and pharmaceutical compositions containing them |
| 02/03/1993 | EP0526267A1 Polyfluoroalkylthiopoly(ethylimidazolium) compounds, process for their preparation, and their use as biocidal agents |
| 02/03/1993 | EP0526253A1 1,3-Oxathiolane nucleoside analogues |
| 02/03/1993 | EP0526200A1 2-(Imidazol-1-YL)-2-benzyl-ethylidene-aminoxyalkanoic acid derivatives as thromboxane A2 inhibitors |
| 02/03/1993 | EP0526171A2 Crystals of N-(trans-4-isopropylcyclohexylcarbonyl)-D-phenylalanine and methods for preparing them |
| 02/03/1993 | EP0526009A1 Inhibitors of hiv protease useful for the treatment of aids |
| 02/03/1993 | EP0526004A1 Pyrazolopyrimidinone antianginal agents |
| 02/03/1993 | EP0526001A1 Substituted triazolinones |
| 02/03/1993 | EP0525973A2 Substituted azetidinones as anti-inflammatory and antidegenerative agents |
| 02/03/1993 | EP0525960A1 Use of rapamycin for the treatment of adult T-cell leukemia/lymphoma |
| 02/03/1993 | EP0525938A1 Gallium compounds |
| 02/03/1993 | EP0525917A2 Double-stranded RNA correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles |
| 02/03/1993 | EP0525888A1 New catechol type non-steroidal drugs as 5-alpha reductase inhibitors |
| 02/03/1993 | EP0525885A1 New sulphur containing nonsteroidal drugs as 5-alpha reductase inhibitors |
| 02/03/1993 | EP0525879A1 Pyrazole derivatives |
| 02/03/1993 | EP0525846A1 Sporomiella intermedia and processes therefrom |
| 02/03/1993 | EP0525814A1 Use of di-tertbutylhydroxyphenyl derivatives for the therapy of inflammatory conditions of the gastrointestinal tract |
| 02/03/1993 | EP0525768A1 Tetralones with pharmacological activity |
| 02/03/1993 | EP0525686A1 Dimethylacetylacetic acid amides, process for their preparation and pharmaceutical compositions |
| 02/03/1993 | EP0525629A2 5-membered heterocycles, process for their preparation and medicaments containing them |
| 02/03/1993 | EP0525589A1 Asymmetric synthesis of taxol side chain |
| 02/03/1993 | EP0525588A2 Production of pradimicin antibiotics by actinomadura strain |
| 02/03/1993 | EP0525584A1 6-Oxo-azepinoindole derivatives, process and intermediates for their preparation and medicaments containing them |
| 02/03/1993 | EP0525573A1 Organogermanium and organosilicon compounds, process for the preparation of the same and use thereof |
| 02/03/1993 | EP0525571A1 Quinolin-2-yl-methoxybenzylhydroxyureas as lipoxygenase inhibitors |
| 02/03/1993 | EP0525568A1 N-Alkylated 1,4-dihydropyridine carboxylicacid ester derivatives |
| 02/03/1993 | EP0525537A1 Use of 1,4-dihydropyridine derivatives for the preparation of a medicament for the treatment of neuropathies caused by diabetes mellitus |
| 02/03/1993 | EP0525516A2 Derivatives of beta substituted cinnomic acid |
| 02/03/1993 | EP0525499A1 Amide derivatives of antibiotic A 40926 |
| 02/03/1993 | EP0525479A1 Spicamycin derivatives and the use thereof |
| 02/03/1993 | EP0525475A2 A beta-blocker and carbachol containing antiglaucoma composition |
| 02/03/1993 | EP0525472A2 Methylen-oxindole derivatives and process for their preparation |
| 02/03/1993 | EP0525420A1 Pseudopeptides and dipeptides characterised by a substituted methyl ketone moiety at the C-terminus as thiol protease inhibitors |
| 02/03/1993 | EP0525388A1 Suckable or chewable tablet |
| 02/03/1993 | EP0525307A1 Stable compositions for parenteral administration and their use |
| 02/03/1993 | EP0525262A1 Anti-inflammatory cosmetic composition |
| 02/03/1993 | EP0525236A1 Method for obtaining an anti-diarrhoea product based on carob |
| 02/03/1993 | EP0525167A1 Sustained drug release through topical application of bioadhesive liposomes. |
| 02/03/1993 | EP0525158A1 Hyperglycemic compositions |
| 02/03/1993 | EP0525145A1 Process for producing ergolin derivatives |
| 02/03/1993 | EP0525129A1 Substituted benzimidazoles |
| 02/03/1993 | EP0525109A1 Styryl-substituted monocyclic and bicyclic heteroaryl compounds which inhibit egf receptor tyrosine kinase |
| 02/03/1993 | EP0525106A1 2',3'-dideoxy-4'-thioribonucleosides as antiviral agents |
| 02/03/1993 | EP0525083A1 Erythromycin derivatives |
| 02/03/1993 | EP0525057A1 Antimicrobial quinolonyl lactams |
| 02/03/1993 | EP0525055A1 Improved iontophoretic administration of drugs |
| 02/03/1993 | EP0525033A1 4-(oxygen, sulfur or nitrogen substituted)-methyl 5-hydroxy-2(5h)-furanones as anti-inflammatory agents |
| 02/03/1993 | EP0525023A1 Novel pyridine esters |
| 02/03/1993 | EP0525010A1 Use of minoxidil for treating erectile impotence |
| 02/03/1993 | EP0525002A1 2[5H]-FURANONES SUBSTITUTED IN THE 3 POSITION, AS Ca 2+ CHANNEL ANTAGONISTS AND ANTI-INFLAMMATORY AGENTS |
| 02/03/1993 | EP0524997A1 2'-o-alkyl nucleotides and polymers containing them. |
| 02/03/1993 | EP0524979A1 2(5h)-furanones substituted in the 5 and or in the 4 position, as anti-inflammatory agents |
| 02/03/1993 | EP0524974A1 Pyridines as medicaments |
| 02/03/1993 | EP0524961A1 Azo-derivatives, pharmaceutical preparations containing them, and their use against aids. |
| 02/03/1993 | EP0524946A1 Treatment of central nervous system disorders with imidazole angiotensin-ii receptor antagonists |
| 02/03/1993 | EP0308476B1 Bisphenylalkylpiperazine derivatives, a method of their preparation and a pharmaceutical preparation |
| 02/03/1993 | CN1068574A Atp analogues |
| 02/03/1993 | CN1068573A Process for preparing phosphino-hydrocarbon-group viii-metal complexes and antitumor composition containing these complexes |
| 02/03/1993 | CN1068571A Substituted 3-aminoquinuclidines |
| 02/03/1993 | CN1068570A Antiviral combinations |
| 02/03/1993 | CN1068569A Dithiane |
| 02/03/1993 | CN1068568A Benzofuran derivatives and pharmaceutical composition |
| 02/03/1993 | CN1068566A Alpha-(4-hydroxypiperidino)-1-alkanol derivatives as antiischemic agents |
| 02/03/1993 | CN1068494A Compound |
| 02/03/1993 | CA2074999A1 Cholesterol-lowering compounds |